Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
about
Natriuretic Peptides and Cardiometabolic HealthHighlights of the year in JACC 2012Atrial natriuretic peptide in cardiovascular biology and disease (NPPA)PCSK6-mediated corin activation is essential for normal blood pressureCorin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting. [Corrected]C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.Corin in natriuretic peptide processing and hypertensionA corin variant identified in hypertensive patients that alters cytoplasmic tail and reduces cell surface expression and activityThe C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.Gene Polymorphisms of FABP2, ADIPOQ and ANP and Risk of Hypertriglyceridemia and Metabolic Syndrome in Afro-Caribbeans.Atrial natriuretic Peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation.Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis.Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study.Sex Differences of the Natriuretic Peptide Polymorphism Associated With Angiographic Coronary Atherosclerosis.Significant association between functional microRNA polymorphisms and coronary heart disease susceptibility: a comprehensive meta-analysis involving 16484 subjects.Natriuretic peptides in cardiovascular diseases: current use and perspectivesAtrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases.Bridging the Gap between Translational and Outcome Research in Cardiovascular DiseaseC2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro.The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases.T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients.Dynamic expression of early responsible genes to acute left-ventricular ischemia in a time-dependent pattern
P2860
Q26827702-54E1651F-D4F5-40B4-8172-3C4C660F6772Q26865608-F867AB5B-5206-461B-93F7-B05F16E6946FQ28082833-3D89BF94-8385-4E6F-9869-38320FD117D3Q28266080-901D17A4-A8F3-448E-AC96-D5D989169D80Q33793053-0B4B568B-DBAF-4ADD-9EDD-AD00C6B91C90Q33812913-21462F44-E689-45BA-89BF-72DCE0D95705Q34396853-38203076-920A-408F-A9FF-357A26B8426DQ34452715-7ED40D1D-B66F-40CC-9609-6567F974AD90Q35425744-60B99DE8-A189-4CA1-B4E4-A595EE8921C3Q36148177-C9991E89-A119-4974-90A3-9773798A509BQ37195866-265EE980-236D-43CA-8815-2315F339DCDDQ37209666-EAD228B0-A539-4AA9-9810-1E1F9DF7A3E2Q37638257-D8C1DD59-F908-440E-A0CA-7F692737E428Q37684980-67472CF6-9743-4C91-8778-0A8617FD3A73Q37701464-689FDD77-FDBB-4148-9867-D6250054E62DQ38162429-CC8325C8-03B0-488C-A86D-80AA69389260Q38194620-EE874BFD-48AD-458B-8540-9B4328C80893Q42060323-BBC86910-FB60-4C1B-AE27-B18455C16706Q43076955-038B666D-C876-46D6-B333-9530F7E18E92Q50034119-4A56CDB2-746C-4D29-98C6-BC9DB438BCFDQ50055077-75EA45C8-C8BF-4DDA-9F75-4C710C891158Q58270843-7FEFBA3A-46F8-4B12-BA7B-BA1F5970EDC3
P2860
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
@en
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
@nl
type
label
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
@en
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
@nl
prefLabel
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
@en
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
@nl
P2093
P50
P1476
Influence of rs5065 atrial natriuretic peptide gene variant on coronary artery disease.
@en
P2093
Anna Evangelista
Bernard De Bruyne
Giusy Sirico
Jozef Bartunek
Keith A A Fox
Leen Delrue
Peter Sinnaeve
Sara Di Castro
Speranza Rubattu
Stefaan Janssens
P304
P356
10.1016/J.JACC.2012.02.017
P407
P50
P577
2012-05-01T00:00:00Z